Immune Therapy Holdings AB or ITH is a Swedish biotechnology R&D holding company headquartered at the Karolinska Institutet and Karolinska University Hospital in Stockholm. ITH's research is primarily focused on its Tailored Leukapheresis (TLA) treatment for immune mediated inflammatory diseases (IMIDs). Tailored Leukapheresis (TLA) treatment is an apheresis immunotherapy for selective removal of disease-causing pro-inflammatory cells extracorporeally, which has therapeutic application in various IMIDs that are caused and maintained by inflammation. More information...
According to PR-model, ithgroup.eu is ranked 2,626,490th in multilingual Wikipedia, in particular this website is ranked 65,759th in Swedish Wikipedia.
The website is placed before euclideanrelativity.com and after stenungsundsif.se in the BestRef global ranking of the most important sources of Wikipedia.
